145 related articles for article (PubMed ID: 15207259)
1. The mouse ortholog of the neuronal ceroid lipofuscinosis CLN5 gene encodes a soluble lysosomal glycoprotein expressed in the developing brain.
Holmberg V; Jalanko A; Isosomppi J; Fabritius AL; Peltonen L; Kopra O
Neurobiol Dis; 2004 Jun; 16(1):29-40. PubMed ID: 15207259
[TBL] [Abstract][Full Text] [Related]
2. The neuronal ceroid lipofuscinosis protein CLN5: new insights into cellular maturation, transport, and consequences of mutations.
Schmiedt ML; Bessa C; Heine C; Ribeiro MG; Jalanko A; Kyttälä A
Hum Mutat; 2010 Mar; 31(3):356-65. PubMed ID: 20052765
[TBL] [Abstract][Full Text] [Related]
3. A mouse model for Finnish variant late infantile neuronal ceroid lipofuscinosis, CLN5, reveals neuropathology associated with early aging.
Kopra O; Vesa J; von Schantz C; Manninen T; Minye H; Fabritius AL; Rapola J; van Diggelen OP; Saarela J; Jalanko A; Peltonen L
Hum Mol Genet; 2004 Dec; 13(23):2893-906. PubMed ID: 15459177
[TBL] [Abstract][Full Text] [Related]
4. The neuronal ceroid lipofuscinosis Cln8 gene expression is developmentally regulated in mouse brain and up-regulated in the hippocampal kindling model of epilepsy.
Lonka L; Aalto A; Kopra O; Kuronen M; Kokaia Z; Saarma M; Lehesjoki AE
BMC Neurosci; 2005 Apr; 6():27. PubMed ID: 15826318
[TBL] [Abstract][Full Text] [Related]
5. CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis.
Savukoski M; Klockars T; Holmberg V; Santavuori P; Lander ES; Peltonen L
Nat Genet; 1998 Jul; 19(3):286-8. PubMed ID: 9662406
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of lysosomal acid phosphatase in CLN3-defective cells and mouse brain tissue.
Pohl S; Mitchison HM; Kohlschütter A; van Diggelen O; Braulke T; Storch S
J Neurochem; 2007 Dec; 103(6):2177-88. PubMed ID: 17868323
[TBL] [Abstract][Full Text] [Related]
7. A mutation in canine CLN5 causes neuronal ceroid lipofuscinosis in Border collie dogs.
Melville SA; Wilson CL; Chiang CS; Studdert VP; Lingaas F; Wilton AN
Genomics; 2005 Sep; 86(3):287-94. PubMed ID: 16033706
[TBL] [Abstract][Full Text] [Related]
8. Neuronal ceroid lipofuscinosis genes, CLN2, CLN3 and CLN5 are spatially and temporally co-expressed in a developing mouse brain.
Fabritius AL; Vesa J; Minye HM; Nakano I; Kornblum H; Peltonen L
Exp Mol Pathol; 2014 Dec; 97(3):484-91. PubMed ID: 25303899
[TBL] [Abstract][Full Text] [Related]
9. CLN5 mutations are frequent in juvenile and late-onset non-Finnish patients with NCL.
Xin W; Mullen TE; Kiely R; Min J; Feng X; Cao Y; O'Malley L; Shen Y; Chu-Shore C; Mole SE; Goebel HH; Sims K
Neurology; 2010 Feb; 74(7):565-71. PubMed ID: 20157158
[TBL] [Abstract][Full Text] [Related]
10. Cln5-deficiency in mice leads to microglial activation, defective myelination and changes in lipid metabolism.
Schmiedt ML; Blom T; Blom T; Kopra O; Wong A; von Schantz-Fant C; Ikonen E; Kuronen M; Jauhiainen M; Cooper JD; Jalanko A
Neurobiol Dis; 2012 Apr; 46(1):19-29. PubMed ID: 22182690
[TBL] [Abstract][Full Text] [Related]
11. Positional cloning of the CLN5 gene defective in the Finnish variant of the LINCL.
Klockars T; Savukoski M; Isosomppi J; Peltonen L
Mol Genet Metab; 1999 Apr; 66(4):324-8. PubMed ID: 10191122
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of storage pathology in prenatal CLN5-deficient sheep neural cultures by lentiviral gene therapy.
Hughes SM; Hope KM; Xu JB; Mitchell NL; Palmer DN
Neurobiol Dis; 2014 Feb; 62():543-50. PubMed ID: 24269732
[TBL] [Abstract][Full Text] [Related]
13. Lysosomal localization of the neuronal ceroid lipofuscinosis CLN5 protein.
Isosomppi J; Vesa J; Jalanko A; Peltonen L
Hum Mol Genet; 2002 Apr; 11(8):885-91. PubMed ID: 11971870
[TBL] [Abstract][Full Text] [Related]
14. Lysosomal degradation of cholecystokinin-(29-33)-amide in mouse brain is dependent on tripeptidyl peptidase-I: implications for the degradation and storage of peptides in classical late-infantile neuronal ceroid lipofuscinosis.
Bernardini F; Warburton MJ
Biochem J; 2002 Sep; 366(Pt 2):521-9. PubMed ID: 12038963
[TBL] [Abstract][Full Text] [Related]
15. Topology and membrane anchoring of the lysosomal storage disease-related protein CLN5.
Larkin H; Ribeiro MG; Lavoie C
Hum Mutat; 2013 Dec; 34(12):1688-97. PubMed ID: 24038957
[TBL] [Abstract][Full Text] [Related]
16. CLN6, which is associated with a lysosomal storage disease, is an endoplasmic reticulum protein.
Mole SE; Michaux G; Codlin S; Wheeler RB; Sharp JD; Cutler DF
Exp Cell Res; 2004 Aug; 298(2):399-406. PubMed ID: 15265688
[TBL] [Abstract][Full Text] [Related]
17. Transmembrane protein 50b (C21orf4), a candidate for Down syndrome neurophenotypes, encodes an intracellular membrane protein expressed in the rodent brain.
Moldrich RX; Lainé J; Visel A; Beart PM; Laffaire J; Rossier J; Potier MC
Neuroscience; 2008 Jul; 154(4):1255-66. PubMed ID: 18541381
[TBL] [Abstract][Full Text] [Related]
18. Altered arginine metabolism in the central nervous system (CNS) of the Cln3-/- mouse model of juvenile Batten disease.
Chan CH; Ramirez-Montealegre D; Pearce DA
Neuropathol Appl Neurobiol; 2009 Apr; 35(2):189-207. PubMed ID: 19284480
[TBL] [Abstract][Full Text] [Related]
19. Viral-mediated delivery of the late-infantile neuronal ceroid lipofuscinosis gene, TPP-I to the mouse central nervous system.
Haskell RE; Hughes SM; Chiorini JA; Alisky JM; Davidson BL
Gene Ther; 2003 Jan; 10(1):34-42. PubMed ID: 12525835
[TBL] [Abstract][Full Text] [Related]
20. Two novel CLN5 mutations in a Portuguese patient with vLINCL: insights into molecular mechanisms of CLN5 deficiency.
Bessa C; Teixeira CA; Mangas M; Dias A; Sá Miranda MC; Guimarães A; Ferreira JC; Canas N; Cabral P; Ribeiro MG
Mol Genet Metab; 2006 Nov; 89(3):245-53. PubMed ID: 16814585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
